Improving epidemic control strategies by extended detection by Karp, Pawel et al.
Improving epidemics control strategies by extended detection
Pawe l Karp,1, ∗ Bart lomiej Dybiec,1, † and Adam Kleczkowski2, ‡
1Marian Smoluchowski Institute of Physics, and Mark Kac Center for Complex Systems Research,
Jagiellonian University, ul. Reymonta 4, 30–059 Krako´w, Poland
2Dept. Computing Science and Mathematics, University of Stirling, Stirling FK9 4LA, United Kingdom
(Dated: September 20, 2013)
Majority of epidemics eradication programs work in preventive responsive way. The lack of exact
information about epidemiological status of individuals makes responsive actions less efficient. Here,
we demonstrate that additional tests can significantly increase the efficiency of “blind” treatment
(vaccination or culling). Eradication strategy consisting of “blind” treatment in very limited local
neighbourhood supplemented by extra tests in a little bit larger neighbourhood is able to prevent
invasion of even highly infectious diseases and to achieve this at a cost lower than for the “blind”
strategy. The effectiveness of the extended strategy depends on such parameters as the test efficiency
and test cost.
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I. INTRODUCTION
Many outbreaks of serious diseases of humans (e.g.
SARS [1]), animals (e.g. foot-and-mouth disease [2]),
and plants epidemics (e.g. citrus canker [3] and sudden
oak death [4]) can be described in terms of a spread of
an infectious agent on a network of hosts. This repre-
sentation can then successfully be used to design control
strategies [5, 6, 18–27]. However, two factors limit the
use of modelling for real systems. Firstly, the topology
of the network is usually not completely known as we
do not possess a full information on which nodes are in
contact with which. Secondly, the status of individuals,
whether they are susceptible, infected, infectious or re-
moved/recovered, is often not known. We have shown
[5–7] that despite these drawbacks it is possible to design
control strategies optimal in a combined epidemiological
and economic sense.
Any successful control strategy for infectious diseases
needs to balance at least two conflicting goals. On one
hand, it aims at a quick eradication of the disease agent.
Thus, from purely epidemiological point of view, the best
approach would be to remove all the cases (sources of in-
fection) immediately. At the same time, due to limited
resources and time constraints, the epidemic has to be
controlled at manageable costs within realistic time win-
dow. The solution is to find a mixture of preventive and
responsive local or global treatments [5, 6, 8]. Poten-
tial treatments can include vaccination, culling, or even
isolation (quarantine) of individuals.
In this paper we consider an epidemic that spreads on a
network with local nearest-neighbour interactions. Con-
trol measures which are triggered by certain events are
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applied locally within a fixed range. However, in exten-
sion to previous work, we also consider further diagnostic
tests which are performed on all agents located within a
test range. The positive results of diagnostic tests lead
to further treatment (within the same fixed radius as the
initial control action) centered on diagnosed individuals.
Consequently, the suggested strategy is a mixture of a
local “blind” strategy [9, 10] and “live test” strategy; the
latter originally proposed to attempt to eradicate bovine
tuberculosis [11–13]. The designers of the strategy in-
volving tests claim that it leads to a lower number of
badgers killed than the “clean ring” strategy in which
all badgers are killed in a certain radius from a focus of
infection. The “clean ring” strategy usually results in
unnecessary killing of healthy individuals and the use of
diagnostic tests shifts the standard responsive (event trig-
gered) “blind” control strategy to the proactive regime.
Thus, application of diagnostic tests makes the eradica-
tion strategy more selective in comparison to the clean
ring strategy, which extends the control radius until ring
of uninfected individuals is removed.
In our paper we firstly present the model and define
the cost associated with the control strategy. We assume
that control strategy is purely local, however, it is supple-
mented by additional diagnostic tests. We subsequently
study the sensitivity of the cost to the choice of the con-
trol radius as defined in [6, 9, 10], of the test radius and
of the test sensitivity. We show that under certain con-
ditions additional testing can improve efficiency of local
control strategies in comparison to purely local methods.
II. MODEL AND RESULTS
The model extends the basic SIR (susceptible – in-
fectious – recovered) epidemiological model [14, 15] by
introduction of two additional classes: detected (infec-
tious symptomatic) and vaccinated/treated [5]. Our pa-
per is focused on the optimization of control strategies
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FIG. 1: The diagram showing possible states of individuals
and allowed transitions. Labels assigned to links represent
probabilities of given transitions. Transitions to the infec-
tious state (I) can be induced by contact with any infectious
individual (I or D). During a treatment not only the detected
individual is vaccinated but also its nearest neighbours up to
the order zv, what is schematically indicated by the dashed
line.
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FIG. 2: Schematic representation of the extended control
strategy: solid lines represent treatment neighbourhoods (zv)
while dashed line the test neighbourhood (zt). An detected
individual D can trigger a control measure with probability v.
If a control measure is applied, every detected D individual
in the test neighbourhood (zt) triggers a treatment of all its
local neighbours up to zv. Also a susceptible individual or in-
fectious individual can trigger a treatment with probabilities
p(+|S) = tf and p(+|S) = te respectively.
when exact epidemiological status of each individual is
unknown – in particular when only detected individu-
als can be observed by public health authorities. In this
paper we consider an additional testing procedure that
can be used to distinguish between different classes of
individuals. However, this procedure is associated with
additional costs and is not perfect.
A. Model
The system consist of N individuals placed on a regular
square lattice with periodic boundary conditions. Every
individual can be in one of the following states
S – susceptible,
I – infected pre-symptomatic,
D – infected symptomatic (detected),
R – recovered,
V – vaccinated.
Possible transitions between states are presented in
Fig. 1. There is no return transition from the vaccinated
or recovered state to the susceptible state, i.e. treatment
or recovery result in perfect, permanent immunity (from
the mathematical point of view vaccinated and recovered
states are absorbing). Any susceptible individual can
be infected due to a contact with an infectious (infected
or detected) individual, with probability p per contact.
Infectious individuals start to display symptoms after a
spontaneous transition to the detected class, with prob-
ability q; subsequently they can recover with probability
r. In addition, every detected individual can trigger a
control event with probability v. This results in a series
of actions taken by the health authorities in order to stop
the disease from spreading.
Basic strategy: In the simplest case, the control ac-
tion will consist of treatment of the detected individual
together with all its local neighbours up to the order zv
(basic strategy). This strategy corresponds to a “blind”
strategy as it treats all individuals in the neighbourhood
regardless of their status, and it broadly corresponds to
measures used in controlling the foot-and-mouth [2] or
citrus canker [3] diseases. In order to compensate for
the lack of knowledge of exact epidemiological status of
individuals, the treatment is performed in a larger neigh-
bourhood of the detected individual zv in hope of catch-
ing all potentially infected but presymptomatic individ-
uals (zv = 0 correspond to treatment of the detected
individual only).
Extended strategy: The basic strategy assumes that
we only know the location of detected individuals, when
they exhibit visible symptoms. However, in some cases it
might be possible to improve the detectability by intro-
duction of additional testing. As before, every infectious
symptomatic individual (D) triggers a control measure
with probability v, but this time the control event con-
sists of two steps:
1. The detected individual together with (all) its near-
est neighbours up to the zv order are vaccinated.
2. In addition to step 1, state dependent actions are
performed on all local neighbours up to the order
zt (test range) of the detected individual, as follows
3S – additional test is performed,
I – additional test is performed,
D – rule 1 is performed and individuals and their
neighbours are treated,
R – no additional action is taken,
V – no additional action is taken.
If result of the test is positive, rule 1 is applied
on the “positive” recognised individuals (which are
then treated together with their neighbours up to
the zv order). Otherwise, no further actions are
taken.
The rules listed above assume that we are able to “vi-
sually” distinguish between R and V classes on one hand
(the individuals might know that they have recovered
from the disease or have been treated; alternatively a
record might exist that proves their status) and S and
I classes on the other hand. It is only the latter two
classes that are tested to determine their exact status
and in particular to detect individuals in the I class. We
do not specify the details of the test; presumably this
can be done by immunological methods similar to the
“live test” procedure for bovine tuberculosis in badgers
[11–13].
The test is characterized by three parameters: te – the
probability of detection of infectious individual given it
is actually infectious, i.e. p(+|I), and tf – the probabil-
ity of false detection, i.e. p(+|S) (we will only study te
in this paper and assume that tf is fixed). In addition,
each test has a price tprice. The extended strategy is pre-
sented schematically in Fig. 2. The control action was
initiated by the detected individual located in the cen-
tre. First, all individuals within the small (solid lines)
diamond are treated. Second, all individuals within the
larger (broken lines) diamond are tested. All individuals
in class D trigger further action (diamond centred around
the second individual D). All individuals that test diag-
nosed positively (whether they in reality are S or I) also
trigger further treatment events (two diamonds centred
around individuals S and I). The treatment range zv and
test range zt are two independent parameters, however,
the most efficient control strategy corresponds to zt > zv
with low zv, see below.
The main aim of the paper is to compare efficiency
of the basic strategy (with fixed zv) with the extended
strategy (with the same zv and varying zt). The com-
parison is done by using the overall cost associated with
the eradication strategy is X = V +R (basic strategy) or
X = V +R+ tprice×NT (extended strategy), where V,R
and NT represent the number of vaccinated individuals,
recovered individuals and the total number of performed
test respectively.
B. Results
The model described in Sec. A has been studied by sim-
ulations. First, for the reference, the results for the basic
eradication strategy are presented. Next, it is shown how
and when the extended strategy can outperform the basic
control strategy.
The simulations have been performed for r = 0.01 (re-
covery probability), v = 0.5 (treatment probability), tf =
0.05 = p(+|S) (probability of false detection), p = 2pexp
(infection probability) and q = 0.2 (probability of symp-
toms occurrence). The test range is zt = {0, 1, 2, 3}, the
treatment range is zv = {1, 2, 3, 4}, however we concen-
trate on the results for zv = 1. This corresponds to the
worst-case scenario for the basic strategy. Thus, if test-
ing can indeed improve the overall performance, this will
be easier to assess for zv = 1 than for zv > 1.
1. Basic strategy – no testing
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FIG. 3: Cost of the basic control strategy X (zt = 0) for
various treatment ranges: zv = {1, 2, 3, 4}. Other simulation
parameters q = 0.2, r = 0.01, v = 0.5. Results have been
averaged over 100 realizations. System size is 200×200. Error
bars represent standard deviation of the mean.
Figure. 3 presents results for the basic strategy, i.e.
strategy without tests. Here, the cost of control strategy
X is defined as X = V + R, where V and R are num-
bers of vaccinated and recovered individuals respectively,
i.e. it is the number of individuals affected (directly or
indirectly) by the epidemic outbreak. The total cost X
increases as the infection probability p increases, for all
values of the control neighbourhood, zv. Rapid increase
in X for a certain value of p corresponds to a switch from
non-invasive, fully controlled epidemic to an invasive one
which is no longer controlled. We do not show the results
for R and V separately, but simulations show that in this
case the cost of control strategy is dominated by treat-
4ment, i.e. epidemic runs out of control and it is necessary
to treat the whole population. The main effect of chang-
ing zv is to shift the critical value of p towards higher
probabilities. This means that the higher zv is, any out-
break of the more infectious disease can successfully be
stopped by application of such a strategy.
However, for a fixed p the relationship between X and
zv is non-trivial. For very small p, smaller treatment
range (zv) generates smaller overall cost of eradication
strategy. As p increases, the strategy with zv = 1 be-
comes insufficient and the number of vaccinated individ-
uals and consequently the overall cost X increase rapidly
(crosses in Fig. 3). As a result zv = 2 leads to the low-
est value of X and so can be interpreted as an optimal
strategy. This process is repeated for higher values of p,
as zv = 3 and subsequently zv = 4 become optimal. For
parameters considered here zv = 4 stays optimal even for
p close to 1.
2. Extended strategy
For the extended control strategy, the total cost of the
epidemic includes an additional component due to test-
ing, i.e. X = V + R + tprice × NT , where tprice is the
price of a single test while NT is the total number of
tests performed. In order to explore the effect of testing,
we assume the worst case scenario for the basic strategy,
zv = 1. We also initially assume that the test is not very
efficient, te = 60%, see Fig. 4 and later which explore the
dependence of the results on te.
The increase in the infectivity is now compensated not
by the increase in the treatment range zv (as for the ba-
sic strategy, see Fig. 3), but by introduction of testing
in the neighbourhood of size zt which varies from zt = 0
(no testing, see Fig. 3) to zt = 3. For zt = 0 and zt = 1,
the dependence on p is characterised by the threshold
behaviour, with no invasion for small values of p and in-
vasion followed by treatment of almost whole population
for large p (compare Fig. 3 with Fig. 4). However, for
zt = 1 the threshold value of p is shifted towards much
higher values with only minimal increase in overall costs
for small p. Thus, although zt = 0 is optimal for sub-
critical epidemics (small p), the addition of testing sig-
nificantly improves the efficiency of the control in a large
range of p (up to p ' 0.43, see Fig. 4). Increasing the
radius of testing neighbourhood from zt = 1 to zt = 2
increases the overall cost, X, for small to medium val-
ues of p, but it removes the threshold behaviour entirely.
Testing with zt = 1 still leads to the smallest value of
X for p . 0.43 at which point zt = 2 becomes optimal.
Further increase in the testing effort (to zt = 3) consis-
tently increases the costs in the whole range of p values.
We therefore conclude that for this combination of other
parameters, zt = 0 is optimal for very small values of
p (where we would not have treated anyway), zt = 1 is
optimal for p . 0.43, and zt = 2 is optimal afterwards.
Thus, even if the test is relatively inefficient, te = 60%, it
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FIG. 4: Cost of the extended control strategy X as a function
of the probability of spread, p, for different values of zt, with
zt = 0 corresponding to no testing; top panel: low test effi-
ciency, te = 0.6, bottom panel: high test efficiency, te = 0.9.
Other parameters: zv = 1, tprice = 0.25, q = 0.2, r = 0.01,
v = 0.5. Results have been averaged over 100 realizations.
System size is 200× 200. Error bars represent standard devi-
ation of the mean.
is always preferable to combine “blind” treatment with
testing, providing the cost is low (tprice = 0.25).
Increasing the efficiency of testing from te = 0.6 (mean-
ing that 40% of infectious individuals are misdiagnosed
as non-infectious) to te = 0.9 makes zt = 1 the optimal
solution even for very high values of p, see the bottom
panel of Fig. 4. There is no threshold behaviour for zt > 0
and so epidemics are controlled even for very high values
of p.
Returning to te = 0.6 we now study the effect of chang-
ing the test price, tprice, on the choice of the control strat-
egy. Decrease in the cost of testing does not change the
picture qualitatively; the main effect is the overall reduc-
tion in the total cost, X, compare top panel of Fig. 4
with Fig. 5. The reduction in tprice also reduces values
of the infection probability p at which the optimal strat-
egy changes from zt = 1 to zt = 2 (from p ' 0.43 for
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FIG. 5: Similar to Fig. 4, but for the lower test cost, tprice =
0.05 per test. Other parameters: zv = 1, te = 0.6, q = 0.2,
r = 0.01, v = 0.5. Results have been averaged over 100
realizations. System size is 200 × 200. Error bars represent
standard deviation of the mean.
tprice = 0.25 to p ' 0.38 for tprice = 0.05).
Finally, we study a combined effect of changing (zv, zt)
on the choice of the optimal strategy. In Fig. 6 we have
shown the dependence of both test range zt (individ-
ual curves) and treatment range zv (individual panels).
There is very little qualitative effect of changing zv on
the dependence of X on zt; the strategy with zt = 1 is
always the best of the three, even though the actual val-
ues of X vary. There is also no threshold behaviour with
respect to p for zt > 0; addition of testing always stops
any epidemic considered here.
However, comparison of the results with zt = 0 and
zt = 1 for zv > 1 reveal an interesting result. Although
for zv = 1 the strategy without testing (zt = 0) is al-
most always less efficient than with testing (zt = 1),
this changes when zv is increased. As treatment radius
zv increases, the range of the infection probability p for
which zt = 0 is optimal is enlarged. Putting it differently,
for large zv the “blind” control strategy (basic strategy)
can outperform the extended strategy (strategy with the
test). Nevertheless, even for zv = 3 there is still a consid-
erable interval of p values for which the extended strat-
egy is better than the basic strategy, see bottom panel of
Fig. 6.
III. SUMMARY AND CONCLUSIONS
Efficient eradication of epidemics relies on quick and
efficient control measures. The lack of knowledge of ex-
act epidemiological status of each individual makes re-
sponsive actions more complicated and potentially less
efficient. One possible solution to this problem is to in-
crease the treatment range in order to compensate for
the lack of knowledge about the status of individuals.
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FIG. 6: Similar to Fig. 4 (bottom panel), but for different
values of zv, top panel: zv = 1 (identical to bottom panel
of Fig. 4, but shown here for completeness), middle panel:
zv = 2, bottom panel: zv = 3. Other parameters: te = 0.9,
tprice = 0.25, q = 0.2, r = 0.01, v = 0.5. Results have been
averaged over 100 realizations. System size is 200×200. Error
bars represent standard deviation of the mean.
Alternative solution considered in this paper is based on
additional tests which can improve early detection of in-
6fectious pre-symptomatic individuals.
Our basic strategy assumes “blind” treatment of all
local neighbours within a given radius. Thus, it could
lead to unnecessary waste of resources which are used
for treatment of healthy individuals especially in situa-
tions when treatment range is large. This is the general
drawback of the “clean ring” strategy considered in the
context of bovine tuberculosis control [11–13]. Extended
strategy as proposed here acts in a more selective (proac-
tive) way since an initial control event is followed by
responsive actions driven by the epidemiological status
of individuals. Consequently, “blind” treatment in small
neighbourhood supplemented by tests in a little bit larger
neighbourhood result in lower overall cost of eradication
of epidemic than the “blind” treatment. One of our key
results is to show that complementing the “blind” strat-
egy with a minimal treatment range (zv = 1) by test-
ing with a minimal radius (zt = 1) followed by another
round of treatment is sufficient to stop outbreaks of an
even highly infectious disease. We also show that high
test efficiency is crucial for high overall performance of
the control strategy. This result is analogous to the one
for the “live test” strategy [11–13].
The extended strategy avoids several disadvantages of
the “clean ring” strategy because “blind” treatment is
performed in the limited range only. The control area is
extended in the selective (proactive) way by the diagnos-
tic tests which are performed on the all (potentially infec-
tious) individuals within the test range. This results in
a relative large number of tested individuals, in turn im-
proving relatively poor statistics of the “live test” strat-
egy [11–13]. Consequently, combined action of “blind”
treatment (in small neighbourhood) and diagnostic test
improves the efficiency of local “blind” (basic) control
strategy.
Our work can be extended in a number of ways.
Firstly, optimisation in our case has only been performed
with respect to one variable. We first fix treatment range
zv and then look for optimisation with respect to the test
range zt (with sensitivity analysis to study the depen-
dence of the results on the test efficiency te and test price
tprice). In reality, the policy maker can optimise with re-
spect to both zv and zt, exploring trade offs between
treatment and testing. Secondly, our results assume that
treatment costs are the same as infection costs. Thus,
in a more general formula for X = cV + R we have as-
sumed c = 1. This assumption can be relaxed, see [6, 7].
Thirdly, we only considered selected values of te and tprice
and a more systematic sensitivity analysis remains to be
done. Fourthly, we only studied one parameter char-
acterising the test efficiency, te; the remaining parame-
ter describing the probability of false positives has been
fixed. Finally, we used a very simple network; more com-
plicated networks have been considered in this context
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